A novel deletion in progranulin gene is associated with FTDP-17 and CBS

Luisa Benussi, Giuliano Binetti, Elena Sina, Lara Gigola, Thomas Bettecken, Thomas Meitinger, Roberta Ghidoni

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

In the last decade familial frontotemporal dementia (FFTD) has emerged as a distinct clinical disease entity characterized by clinical and genetic heterogeneity. Here, we provide an extensive clinical and genetic characterization of two Italian pedigrees presenting with FFTD (FAM047: 5 patients, 5 unaffected; FAM071: 4 patients, 11 unaffected). Genetic analysis showed a conclusive linkage (LOD score for D17S791/D17S951: 4.173) to chromosome 17 and defined a candidate region containing MAPT and PGRN genes. Recombination analysis assigned two different disease haplotypes to FAM047 and FAM071. In affected subjects belonging to both families, we identified a novel 4 bp deletion mutation in exon 7 of PGRN gene (Leu271LeufsX10) associated with a variable clinical presentation ranging from FTDP-17 to corticobasal syndrome. The age-related penetrance was gender dependent. Both mutations in MAPT and PGRN genes are associated with highly variable clinical phenotypes. Despite the profound differences in the biological functions of the encoded proteins, it is not possible to define a clinical phenotype distinguishing the disease caused by mutations in MAPT and PGRN genes.

Original languageEnglish
Pages (from-to)427-435
Number of pages9
JournalNeurobiology of Aging
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Frontotemporal Dementia
Genes
Dementia
Phenotype
Chromosomes, Human, Pair 17
Mutation
Genetic Heterogeneity
Penetrance
Sequence Deletion
Pedigree
Haplotypes
Genetic Recombination
Exons
Proteins

Keywords

  • Corticobasal syndrome
  • Frontotemporal dementia
  • Genotype-phenotype correlation
  • Linkage analysis
  • Mutation
  • PGRN

ASJC Scopus subject areas

  • Clinical Neurology
  • Biological Psychiatry
  • Developmental Neuroscience
  • Neurology
  • Psychology(all)

Cite this

A novel deletion in progranulin gene is associated with FTDP-17 and CBS. / Benussi, Luisa; Binetti, Giuliano; Sina, Elena; Gigola, Lara; Bettecken, Thomas; Meitinger, Thomas; Ghidoni, Roberta.

In: Neurobiology of Aging, Vol. 29, No. 3, 03.2008, p. 427-435.

Research output: Contribution to journalArticle

Benussi, Luisa ; Binetti, Giuliano ; Sina, Elena ; Gigola, Lara ; Bettecken, Thomas ; Meitinger, Thomas ; Ghidoni, Roberta. / A novel deletion in progranulin gene is associated with FTDP-17 and CBS. In: Neurobiology of Aging. 2008 ; Vol. 29, No. 3. pp. 427-435.
@article{4a046e2e9cbc47558a429be349e3ca60,
title = "A novel deletion in progranulin gene is associated with FTDP-17 and CBS",
abstract = "In the last decade familial frontotemporal dementia (FFTD) has emerged as a distinct clinical disease entity characterized by clinical and genetic heterogeneity. Here, we provide an extensive clinical and genetic characterization of two Italian pedigrees presenting with FFTD (FAM047: 5 patients, 5 unaffected; FAM071: 4 patients, 11 unaffected). Genetic analysis showed a conclusive linkage (LOD score for D17S791/D17S951: 4.173) to chromosome 17 and defined a candidate region containing MAPT and PGRN genes. Recombination analysis assigned two different disease haplotypes to FAM047 and FAM071. In affected subjects belonging to both families, we identified a novel 4 bp deletion mutation in exon 7 of PGRN gene (Leu271LeufsX10) associated with a variable clinical presentation ranging from FTDP-17 to corticobasal syndrome. The age-related penetrance was gender dependent. Both mutations in MAPT and PGRN genes are associated with highly variable clinical phenotypes. Despite the profound differences in the biological functions of the encoded proteins, it is not possible to define a clinical phenotype distinguishing the disease caused by mutations in MAPT and PGRN genes.",
keywords = "Corticobasal syndrome, Frontotemporal dementia, Genotype-phenotype correlation, Linkage analysis, Mutation, PGRN",
author = "Luisa Benussi and Giuliano Binetti and Elena Sina and Lara Gigola and Thomas Bettecken and Thomas Meitinger and Roberta Ghidoni",
year = "2008",
month = "3",
doi = "10.1016/j.neurobiolaging.2006.10.028",
language = "English",
volume = "29",
pages = "427--435",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - A novel deletion in progranulin gene is associated with FTDP-17 and CBS

AU - Benussi, Luisa

AU - Binetti, Giuliano

AU - Sina, Elena

AU - Gigola, Lara

AU - Bettecken, Thomas

AU - Meitinger, Thomas

AU - Ghidoni, Roberta

PY - 2008/3

Y1 - 2008/3

N2 - In the last decade familial frontotemporal dementia (FFTD) has emerged as a distinct clinical disease entity characterized by clinical and genetic heterogeneity. Here, we provide an extensive clinical and genetic characterization of two Italian pedigrees presenting with FFTD (FAM047: 5 patients, 5 unaffected; FAM071: 4 patients, 11 unaffected). Genetic analysis showed a conclusive linkage (LOD score for D17S791/D17S951: 4.173) to chromosome 17 and defined a candidate region containing MAPT and PGRN genes. Recombination analysis assigned two different disease haplotypes to FAM047 and FAM071. In affected subjects belonging to both families, we identified a novel 4 bp deletion mutation in exon 7 of PGRN gene (Leu271LeufsX10) associated with a variable clinical presentation ranging from FTDP-17 to corticobasal syndrome. The age-related penetrance was gender dependent. Both mutations in MAPT and PGRN genes are associated with highly variable clinical phenotypes. Despite the profound differences in the biological functions of the encoded proteins, it is not possible to define a clinical phenotype distinguishing the disease caused by mutations in MAPT and PGRN genes.

AB - In the last decade familial frontotemporal dementia (FFTD) has emerged as a distinct clinical disease entity characterized by clinical and genetic heterogeneity. Here, we provide an extensive clinical and genetic characterization of two Italian pedigrees presenting with FFTD (FAM047: 5 patients, 5 unaffected; FAM071: 4 patients, 11 unaffected). Genetic analysis showed a conclusive linkage (LOD score for D17S791/D17S951: 4.173) to chromosome 17 and defined a candidate region containing MAPT and PGRN genes. Recombination analysis assigned two different disease haplotypes to FAM047 and FAM071. In affected subjects belonging to both families, we identified a novel 4 bp deletion mutation in exon 7 of PGRN gene (Leu271LeufsX10) associated with a variable clinical presentation ranging from FTDP-17 to corticobasal syndrome. The age-related penetrance was gender dependent. Both mutations in MAPT and PGRN genes are associated with highly variable clinical phenotypes. Despite the profound differences in the biological functions of the encoded proteins, it is not possible to define a clinical phenotype distinguishing the disease caused by mutations in MAPT and PGRN genes.

KW - Corticobasal syndrome

KW - Frontotemporal dementia

KW - Genotype-phenotype correlation

KW - Linkage analysis

KW - Mutation

KW - PGRN

UR - http://www.scopus.com/inward/record.url?scp=38949174973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949174973&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2006.10.028

DO - 10.1016/j.neurobiolaging.2006.10.028

M3 - Article

C2 - 17157414

AN - SCOPUS:38949174973

VL - 29

SP - 427

EP - 435

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 3

ER -